Skip to main content
. 2007 Jul 17;46(10):914–928. doi: 10.1002/gcc.20479

Table 1.

TheTop 93 Deregulated Genes in Barrett's Adenocarcinomas

Tag sequence UniGene cluster ID Gene symbol Title Location T4 tag count N4 tag count Ratio, T4/N4 P value
Upregulated genes
GTGGCCACGG Hs.112405 S100A9 S100 calcium binding protein A9 1q21 355 0 418 ≤0.001
GAGCAGCGCC Hs.112408 S100A7 S100 calcium binding protein A7 1q21 95 0 112 ≤0.001
AAGATTGGTG Hs.114286 CD9 CD9 antigen (p24) 12p13.3 112 7 10 ≤0.001
GCACCTGTCG Hs.1239 ANPEP Alanyl (membrane) aminopeptidase 15q25‐q26 76 0 89 ≤0.001
GTGACAGAAG Hs.129673 EIF4A1 Eukaryotic translation initiation factor 4A, isoform 1 17p13 92 4 14 ≤0.001
TTTCCTGCTC Hs.139322 SPRR3 Small proline‐rich protein 3 1q21‐q22 308 0 362 ≤0.001
GTTCAAGTGA Hs.186810 REPS2 RALBP1 associated Eps domain containing 2 Xp22.2 107 2 32 ≤0.001
ACTGTATTTT Hs.194691 Hs.194691 G protein‐coupled receptor, family C, group 5, member A 12p13‐p12.3 103 6 10 ≤0.001
TGGATCCTGA Hs.302145 HBG2 Hemoglobin, gamma G 11p15.5 75 0 88 ≤0.001
CAGGAGGAGT Hs.308709 GRP58 Protein disulfide isomerase family A, member 3 15q15 81 2 24 ≤0.001
CTAGTCTTTG Hs.353175 AGPAT4 1‐acylglycerol‐3‐phosphate O‐acyltransferase 4 6q26 85 0 100 ≤0.001
TCACCCAGGG Hs.391464 ABCC1 ATP‐binding cassette, subfamily C member 1 16p13.1 52 0 61 ≤0.001
CCTGGTCCCA Hs.411501 KRT7 Keratin 7 12q12‐q13 179 1 106 ≤0.001
TTCTTTCTAA Hs.411925 TMEM38B Transmembrane protein 38B 9q31.2 58 1 34 ≤0.001
TACCTGCAGA Hs.416073 S100A8 S100 calcium binding protein A8 1q21 343 1 204 ≤0.001
CAGCAGAAGC Hs.424126 SERF2 Small EDRK‐rich factor 2 15q15.3 79 4 12 ≤0.001
GCGGCGGATG Hs.445351 LGALS1 Lectin, galactoside‐binding, soluble, 1 22q13.1 89 0 105 ≤0.001
GAACATTGCA Hs.447579 LOC339290 Hypothetical protein LOC339290 18p11.31 95 0 112 ≤0.001
GTTTGGGTTG Hs.459927 PTMA Prothymosin, alpha (gene sequence 28) 2q35‐q36 162 9 11 ≤0.001
TCACCCACAC Hs.462859 SCFD2 Short‐chain dehydrogenase/reductase 17q12 337 31 6 ≤0.001
CCCCCGCGGA Hs.466507 LISCH7 Liver‐specific bHLH‐Zip transcription factor 19q13.12 48 0 56 ≤0.001
CGGAGACCCT Hs.473583 NSEP1 Y box binding protein 1 1p34 76 2 23 ≤0.001
GCCGGGTGGG Hs.501293 BSG Basigin (OK blood group) 19p13.3 77 4 11 ≤0.001
GATACTTGGA Hs.501911 GALNTL4 Casein kinase 2, alpha 1 polypeptide 11p15.3 94 0 111 ≤0.001
ACAGGCTACG Hs.503998 TAGLN Transgelin 11q23.2 71 3 14 ≤0.001
GTGGCTCACA Hs.504820 MGC14817 Hypothetical protein MGC14817 12q14.3 242 16 9 ≤0.001
TAATTTTTGC Hs.508113 OLFM4 Olfactomedin 4 13q14.3 228 1 136 ≤0.001
GTGAGCCCAT Hs.509736 HSPCB Heat shock 90 kDa protein 1, beta 6p12 149 13 7 ≤0.001
TGTCAGTCTG Hs.512350 Hs.512350 LOC440676 1q21.1 108 1 64 ≤0.001
AGTGCAGGGC Hs.512488 Hs.512488 Similar to 60S ribosomal protein L10 12q21.2 98 1 58 ≤0.001
GCGACCGTCA Hs.513490 ALDOA Aldolase A, fructose‐bisphosphate 16q22‐q24 206 4 31 ≤0.001
ACCGCCGTGG Hs.513803 CYBA Cytochrome b‐245, alpha polypeptide 16q24 77 0 91 ≤0.001
AGCAGGAGCA Hs.515714 S100A16 S100 calcium binding protein A16 1q21 61 0 72 ≤0.001
GATCTCTTGG Hs.516484 S100A2 S100 calcium binding protein A2 1q21 61 0 72 ≤0.001
ATCGTGGCGG Hs.520942 CLDN4 Claudin 4 7q11.23 62 0 73 ≤0.001
CCCAAGCTAG Hs.520973 HSPB1 Heat shock 27 kDa protein 1 7q11.23 175 7 15 ≤0.001
AACATTCGCA Hs.523302 PRDX3 Peroxiredoxin 3 10q25‐q26 46 0 54 ≤0.001
CTTCTCATCT Hs.531719 ADCYAP1 Adenylate cyclase activating polypeptide 1 18p11 85 1 51 ≤0.001
AACTGAGGGG Hs.5333 KIAA0711 Kelch repeat and BTB (POZ) domain containing 11 8p23.3 94 0 111 ≤0.001
GACTCTTCAG Hs.534293 SERPINA3 Serpin peptidase inhibitor, clade A member 3 14q32.1 125 1 74 ≤0.001
CATCGCCAGT Hs.54483 NMI N‐myc (and STAT) interactor 2p24.3‐q21.3 285 0 335 ≤0.001
GACGGCGCAG Hs.546251 ECGF1 Endothelial cell growth factor 1 22q13 46 0 54 ≤0.001
TAGCTTTAAA Hs.554202 SVIL Supervillin 10p11.2 210 0 247 ≤0.001
TGGCCATCTG Hs.555971 PP1201 Transmembrane BAX inhibitor motif containing 1 2p24.3‐p24.1 90 1 54 ≤0.001
CTATCCTCTC Hs.75227 NDUFA9 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39 kDa 12p13.3 51 0 60 ≤0.001
ACTGCCCGCT Hs.81071 ECM1 Extracellular matrix protein 1 1q21 77 1 46 ≤0.001
Downregulated genes
GAGAACCACT Hs.110014 GIF Gastric intrinsic factor (vitamin B synthesis) 11q13 0 87 0.010 ≤0.001
TTGCCCCTAC Hs.128814 CHIA Chitinase, acidic 1p13.1‐p21.3 7 185 0.020 ≤0.001
ACACAGCAAG Hs.131603 Hs.476965 EMI domain containing 2 7q22.1 44 250 0.100 ≤0.001
ACCCTCCCCA Hs.132087 FLJ46299 Kelch domain containing 6 3q21.3 0 35 0.024 ≤0.001
AACCTCCCCG Hs.132858 RAP1GDS1 RAP1, GTP‐GDP dissociation stimulator 1 4q23‐q25 0 33 0.026 ≤0.001
CAGTGCCTCT Hs.133539 MAST4 Microtubule associated serine/threonine kinase family member 4 5q12.3 1 51 0.010 ≤0.001
AACCTCCCAC Hs.134074 ARL2BP Solute carrier family 35, member E1 19p13.11 1 42 0.010 ≤0.001
CTGGCCCTCG Hs.162807 TFF1 Trefoil factor 1 21q22.3 95 174 0.3 ≤0.001
TTTAGGATGA Hs.16757 GDDR Down‐regulated in gastric cancer GDDR 2p13.3 5 474 0.010 ≤0.001
CACCCCTGAT Hs.173724 CKB Creatine kinase, brain 14q32 9 74 0.070 ≤0.001
GACCTCCCCA Hs.178728 MBD3 Methyl‐CpG binding domain protein 3 19p13.3 2 64 0.020 ≤0.001
AGTGCTCTTC Hs.1867 PGC Progastricsin (pepsinogen C) 6p21.3‐p21.1 36 595 0.040 ≤0.001
CCATTCTGAA Hs.209217 ASTN2 Astrotactin 2 9q33.1 0 24 0.035 ≤0.001
CAGTGCTTCC Hs.220864 CHD2 Chromodomain helicase DNA binding protein 2 15q26 5 41 0.070 ≤0.001
GCTGGAGGAA Hs.2681 GAS Gastrin 17q21 0 100 0.009 ≤0.001
CACCTCCCCA Hs.283739 BE614337 Ubiquilin 4 1q21 4 76 0.030 ≤0.001
AGCCTCCCCA Hs.2859 OPRL1 Opiate receptor‐like 1 20q13.33 2 68 0.020 ≤0.001
AAATCCTGGG Hs.2979 TFF2 Trefoil factor 2 (spasmolytic protein 1) 21q22.3 62 1086 0.030 ≤0.001
GCAGGCTCCA Hs.302131 GHRL Ghrelin precursor 3p26‐p25 5 50 0.060 ≤0.001
TGCCAATTAA Hs.307835 PGM5 Phosphoglucomutase 5 9p12‐q12 6 40 0.090 ≤0.001
CCCTGGAAGC Hs.309288 CUGBP2 CUG triplet repeat, RNA binding protein 2 10p13 1 33 0.020 ≤0.001
CTGACTGTGC Hs.36992 ATP4A ATPase, H+/K+ exchanging, alpha polypeptide 19q13.1 10 384 0.020 ≤0.001
GTTTGCTTGC Hs.370480 ABCB7 ATP‐binding cassette, sub‐family B (MDR/TAP), member 7 Xq12‐q13 1 26 0.020 ≤0.001
AACCTCCTCA Hs.386698 C10orf27 Chromosome 10 open reading frame 27 10q22.1 0 29 0.029 ≤0.001
TATATCAGTG Hs.388654 ATP6V1G1 ATPase, H+ transporting, lysosomal 13 kDa, V1 subunit G isoform 1 9q32 3 48 0.040 ≤0.001
AACCTCCCCA Hs.432854 PGA5 Porin, putative 11q13 365 6637 0.030 ≤0.001
GGAACGCAAG Hs.434202 ATP4B ATPase, H+/K+ exchanging, beta polypeptide 13q34 4 138 0.020 ≤0.001
TCTCCATACC Hs.438454 FBXO25 F‐box protein 25 8p23.3 12 376 0.020 ≤0.001
TCCCTTTAAG Hs.438824 CKIP‐1 CK2 interacting protein 1 1q21.2 3 49 0.040 ≤0.001
TTTTTCAAGA Hs.445586 UNQ473 DMC 19q13.2 2 35 0.030 ≤0.001
CAGTGCTCTT Hs.445680 Hs.445680 Similar to anaphase promoting complex subunit 1 2q12.3 1 42 0.010 ≤0.001
ACTGATCTGC Hs.447547 VPS35 Hypothetical protein MGC34800 16q12 5 34 0.090 ≤0.001
TCATTTTGAA Hs.464472 MRCL3 Myosin regulatory light chain MRLC2 18p11.31 0 27 0.031 ≤0.001
CAATGCTTCT Hs.474751 MYH9 Myosin, heavy polypeptide 9, nonmuscle 22q13.1 2 70 0.020 ≤0.001
TGCGAGACCA Hs.490038 CPA2 Carboxypeptidase A2 (pancreatic) 7q32 0 24 0.035 ≤0.001
CATTGCTTCT Hs.516297 TCF7L1 Transcription factor 7‐like 1 (T‐cell specific, HMG‐box) 2p11.2 0 82 0.010 ≤0.001
CAGTGTTCTT Hs.518611 TBC1D14 TBC1 domain family, member 14 4p16.1 2 29 0.040 ≤0.001
AATGTACCAA Hs.523130 LIPF Lipase, gastric 10q23.31 1 51 0.010 ≤0.001
CAGTGCTTCT Hs.527922 DLEU1 Deleted in lymphocytic leukemia, 1 13q14.3 349 8046 0.020 ≤0.001
ACCTCCCCAC Hs.529117 CYP2B7P1 Cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 1 19q13.2 1 41 0.010 ≤0.001
CAGTGCTTTT Hs.551178 Hs.551178 CDNA FLJ46627 fis, clone TRACH2010272 1 60 0.010 ≤0.001
GAGATTATGT Hs.551521 KCNE2 Potassium voltage‐gated channel, Isk‐related family, member 2 21q22.12 5 55 0.050 ≤0.001
TGTACCTCAG Hs.558365 ORM2 Orosomucoid 2 9q32 1 25 0.020 ≤0.001
TCATTCTGAA Hs.69319 GKN1 Gastrokine 1 2p13.3 51 3592 0.010 ≤0.001
AATGTCCCCA Hs.76253 ATXN2 Ataxin 2 12q24.1 2 37 0.030 ≤0.001
TTAACCCCTC Hs.78224 RNASE1 Ribonuclease, RNase A family, 1 (pancreatic) 14q11.2 26 219 0.070 ≤0.001

T4, tag number in all tumor samples tested; N4, tag number in all normal samples. The expression of all genes was significantly altered in at least three tumor samples (P ≤ 0.05), as compared to all normal samples. At least two tumors showed more than fivefold change (P ≤ 0.01). Tags with “0” value were replaced with arbitrary 0.5 values for relative calculation of fold expression. The ratio was calculated after normalization to total tag numbers.